NYSE:GCO - Genesco Stock Price, Price Target & More

Genesco trades on the New York Stock Exchange (NYSE) under the ticker symbol "GCO."

Genesco Inc. (NYSE:GCO) announced its quarterly earnings data on Tuesday, June, 5th. The company reported ($0.06) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The firm earned $645 million during the quarter, compared to analyst estimates of $636.37 million. Genesco had a negative net margin of 3.96% and a positive return on equity of 6.98%. Genesco's revenue was up .2% on a year-over-year basis. During the same period last year, the firm posted $0.05 EPS. View Genesco's Earnings History.

Genesco is scheduled to release their next quarterly earnings announcement on Thursday, August, 30th 2018. View Earnings Estimates for Genesco.

Genesco updated its FY19 earnings guidance on Tuesday, June, 5th. The company provided earnings per share guidance of $3.05-3.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.25.

10 equities research analysts have issued 1 year target prices for Genesco's stock. Their predictions range from $20.90 to $45.00. On average, they anticipate Genesco's stock price to reach $36.3625 in the next year. This suggests that the stock has a possible downside of 12.4%. View Analyst Ratings for Genesco.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesco in the last year. There are currently 9 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Genesco include Foot Locker (FL), DSW (DSW), Boot Barn (BOOT), Finish Line (FINL) and Shoe Carnival (SCVL).

Media coverage about GCO stock has been trending somewhat negative this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Genesco earned a media sentiment score of -0.15 on Accern's scale. They also assigned media stories about the company an impact score of 46.56 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Genesco's stock is owned by many different of institutional and retail investors. Top institutional shareholders include LEGION PARTNERS ASSET MANAGEMENT, LLC (5.17%), Smith Graham & Co. Investment Advisors LP (1.19%) and Bank of Montreal Can (0.15%). Company insiders that own Genesco stock include David Baxter, David M Tehle, Kevin Patrick Mcdermott, Leonard L Berry, Marty G Dickens, Mimi Eckel Vaughn, Robert J Dennis and Thurgood Marshall Jr. View Institutional Ownership Trends for Genesco.

GCO stock was sold by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP. View Insider Buying and Selling for Genesco.

GCO stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can. Company insiders that have bought Genesco stock in the last two years include David Baxter, David M Tehle, Kevin Patrick Mcdermott, Leonard L Berry, Mimi Eckel Vaughn and Robert J Dennis. View Insider Buying and Selling for Genesco.

Shares of GCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of GCO stock can currently be purchased for approximately $41.50.

Genesco has a market capitalization of $784.66 million and generates $2.91 billion in revenue each year. The company earns $-111,830,000.00 in net income (profit) each year or $3.14 on an earnings per share basis. Genesco employs 30,500 workers across the globe.

Genesco's mailing address is GENESCO PK 1415 MURFREESBORO RD, NASHVILLE TN, 37217. The company can be reached via phone at 615-367-7000 or via email at [email protected]